Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against Hepatitis B through incorporation of alum and chitosan

References

• Almeida AJ, Alpar HO, Brown MR. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly (L-lactic acid) microspheres in rats, rabbits and guinea-pigs. The Journal of Pharmacy and Pharmacology 1993; 45: 198–203
   PubMed Web of Science ®Google Scholar
• Alpar HO, Almeida AJ, Brown MR. Microsphere absorption by the nasal mucosa of the rat. Journal of Drug Targeting 1994; 2: 147–149
   PubMed Web of Science ®Google Scholar
• Alving CR, Detrick B, Richards RL, Lewis MG, Shafferman A, Eddy GA. Novel adjuvant strategies for experimental malaria and AIDS vaccines. Annals of the New York Academy of Sciences 1993; 690: 265–275
   PubMed Web of Science ®Google Scholar
• Baras B, Benoit MA, Dupre L, Poulain-Godefroy O, Schacht AM, Capron A, Gillard J, Riveau G. Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen. Infection and Immunity 1999; 67: 2643–2648
   PubMed Web of Science ®Google Scholar
• Bendelac MN, Rivera SH, Parck JH. Mouse CD-1 specific NK1 T cells: Development, specifity and function. Annual Review of Immunology 1997; 15: 535–562
   PubMed Web of Science ®Google Scholar
• Bramwell VW, Somavarapu S, Outschoorn I, Alpar HO. Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids. Journal of Drug Targeting 2003; 11: 525–530
   PubMed Web of Science ®Google Scholar
• Coombes AG, Lavelle EC, Davis SS. Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein. Vaccine 1999; 17: 2410–2422
   PubMed Web of Science ®Google Scholar
• Coombes AG, Lavelle EC, Jenkins PG, Davis SS. Single dose, polymeric, microparticle-based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine 1996; 14: 1429–1438
   PubMed Web of Science ®Google Scholar
• Cox JC, Coulter AR. Adjuvants—a classification and review of their modes of action. Vaccine 1997; 15: 248–256
   PubMed Web of Science ®Google Scholar
• Delgado A, Lavelle EC, Hartshorne M, Davis SS. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Vaccine 1999; 17: 2927–2938
   PubMed Web of Science ®Google Scholar
• Diwan M, Dawar H, Talwar GP. Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable microspheres along with alum. Prostate 1998; 35: 279–284
   PubMed Web of Science ®Google Scholar
• Diwan M, Khar RK, Talwar GP. Tetanus toxoid loaded ‘preformed microspheres’ of cross-linked dextran. Vaccine 2001; 19: 3853–3859
   PubMed Web of Science ®Google Scholar
• Esparza I, Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 1992; 10: 714–720
   PubMed Web of Science ®Google Scholar
• Eyles JE, Bramwell VW, Singh J, Williamson ED, Alpar HO. Stimulation of spleen cells in vitro by nanospheric particles containing antigen. Journal of Controlled Release 2003; 86: 25–32
   PubMed Web of Science ®Google Scholar
• Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Jiang Y, Nagai T. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. Journal of Controlled Release 2006; 112: 35–42
   PubMed Web of Science ®Google Scholar
• Fraser P, Koziel H, Ezekowitz RAB. The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition that link innate and adaptive immunity. Seminars in Immunology 1998; 10: 363–372
   PubMed Web of Science ®Google Scholar
• Gilding DK, Reed AM. Biodegradable polymers for use in surgery—polyglycolic/poly(lactic acid) homo- and copolymers: 1. Polymer 1979; 20: 1459–1464
   Web of Science ®Google Scholar
• Igartua M, Hernandez RM, Esquisabel A, Gascon AR, Calvo MB, Pedraz JL. Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis. International Journal of Pharmaceutics 1998; 169: 45–54
   Web of Science ®Google Scholar
• Ishihara C, Yoshimatsu K, Tsuji M, Arikawa J, Saiki I, Tokura S, Azuma I. Anti-viral activity of sulfated chitin derivatives against Friend murine leukaemia and herpes simplex type-1 viruses. Vaccine 1993; 11: 670–674
   PubMed Web of Science ®Google Scholar
• Iyer S, Robinett RS, Hogenesch H, Hem SL. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine 2004; 22: 1475–1479
   PubMed Web of Science ®Google Scholar
• Jaganathan SKS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally. Vaccine 2006; 24: 4201–4211
   PubMed Web of Science ®Google Scholar
• Johansen P. Men Y, Merkle HP, Gander B. Revisiting PLA/PLGA microspheres: An analysis of their potential in parenteral vaccination. European Journal of Pharmaceutics and Biopharmaceutics 2000; 50: 129–146
   PubMed Web of Science ®Google Scholar
• Kaiserlian D, Etchart N. Epicutaneous and transcutaneous immunization using DNA or proteins. European Journal of Dermatology 1999; 9: 169–176
   PubMed Web of Science ®Google Scholar
• Kanke M, Morlier E, Geissler R, Powell D, Kaplan A, DeLuca PP. Interaction of microspheres with blood constituents II: Uptake of biodegradable particles by macrophages. Journal of Parenteral Science and Technology 1986; 40: 114–118
   PubMedGoogle Scholar
• Kersten GF, Donders D, Akkermans A, Beuvery EC. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen. Vaccine 1996; 14: 1627–1632
   PubMed Web of Science ®Google Scholar
• Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976; 263: 797–800
   PubMed Web of Science ®Google Scholar
• Lee HK, Park JH, Kwon KC. Double-walled microparticles for single shot vaccine. Journal of Controlled Release 1997; 44: 283–293
   Web of Science ®Google Scholar
• Mathiowitz E, Kline D, Langer R. Morphology of polyanhydride microsphere delivery systems. Scanning Microscopy 1990; 4: 329–340
   PubMedGoogle Scholar
• Morris W, Steinhoff MC, Russell PK. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 1994; 12: 5–11
   PubMed Web of Science ®Google Scholar
• Moschos SA, Bramwell VW, Somavarapu S, Alpar HO. Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A. Vaccine 2006; 24: 1081–1086
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 1989; 7: 635–673
   Web of Science ®Google Scholar
• Nellore RV, Pande PG, Young D, Bhagat HR. Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen. Journal of Parenteral Science and Technology 1992; 46: 176–180
   PubMedGoogle Scholar
• O'hagan DT, Jeffery H, Davis SS. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 1993a; 11: 965–969
   PubMed Web of Science ®Google Scholar
• O'hagan DT, McGee JP, Holmgren J, Mowat AM, Donachie AM, Mills KH, Gaisford W, Rahman D, Challacombe SJ. Biodegradable microparticles for oral immunization. Vaccine 1993b; 11: 149–154
   PubMed Web of Science ®Google Scholar
• Rafati H, Coombes AGA, Adler J, Holland J, Davis SS. Protein-loaded poly (DL-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. Journal of Controlled Release 1997; 43: 89–102
   Web of Science ®Google Scholar
• Raghuvanshi RS, Katare YK, Lalwani K, Ali MM, Singh O, Panda AK. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. International Journal of Pharmaceutics 2002; 245: 109–121
   PubMed Web of Science ®Google Scholar
• Shi L, Caulfield MJ, Chern RT, Wilson RA, Sanyal G, Volkin DB. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. Journal of Pharmaceutical Science 2002; 91: 1019–1035
   PubMed Web of Science ®Google Scholar
• Singh J, Pandit S, Bramwell VW, Alpar HO. Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods 2006; 38: 96–105
   PubMed Web of Science ®Google Scholar
• Singh M, Li XM, McGee JP, Zamb T, Koff W, Wang CY, O'hagan DT. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. Vaccine 1997; 15: 475–481
   PubMed Web of Science ®Google Scholar
• Tobio M, Sanchez A, Vila A, Soriana II, Evora C, Vila-Jato JL, Alonso MJ. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids and Surfaces. B, Biointerfaces 2002; 18: 315–323
   Web of Science ®Google Scholar
• Tokumitsu H, Ichikawa H, Fukumori Y, Block LH. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chemical and Pharmaceutical Bulletin 1999; 47: 838–842
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Anderson JM. In vivo biocompatibility studies of medisorb(R) 65/35 D,L-lactide/glycolide copolymer microspheres. Journal of Controlled Release 1993; 24: 81–93
   Web of Science ®Google Scholar
• Yan C, Resau JH, Hewetson J, West M, Rill WL, Kende M. Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. Journal of Controlled Release 1994; 32: 231–241
   Web of Science ®Google Scholar